Gynaecological Cancer League session held at the New Zealand Society for Oncology 2024. Some fantastic talks by Professor Shalmoli Bhattacharya, Bridget Fellows, Dr Kenny Chitcholtan, Dr Magdalena Ratajska, Professor Rodney J. Scott. The delegates also discussed the progress and challenges in terms of HRD testing in Australia and New Zealand. Dr Ratajska eluted the audience on the ongoing HRD assay validation in Dunedin, whereas Professor Scott outlined the challenges and how to overcome the barriers in determining Homologous Recombination Deficiency (HRD) status for access to targeted therapy. The GCL’s aim is to ensure that gynaecological clinicians and scientists remain abreast of developments in their field.
Gynaecological Cancer League session at NZSO 2024
